The Chamber of Commerce, Industries and Agriculture of Panama (Cciap) in conjunction with the Cannabis Association of Panama (Acapan) and the Searching Alternatives Foundation, they see with concern that the Ministry of Health (Minsa) did not open the table for discussion of the regulation of Bill 153 that regulates the medicinal and therapeutic use of cannabis and its derivatives, in order to initiate a dialogue on this issue and take into account their participation in the shortest possible time.
“We want to be part of the table that is drafting the regulation. We have sent a note in this regard to the Minsa and we are still awaiting a formal response, “he said. Jose Ramón Icaza, president of the Cciap.
Furthermore, Icaza said that “It worries that the health authority has not opened the table for discussion of the regulation, which is the most important step after the sanction by the President of the Republic ”.
Among the points pending review in the regulation, there is the number of licenses for the manufacture of medicinal cannabis derivatives; since the law established that Pharmacies and Drugs of the Minsa will be able to define this number up to a maximum of seven licenses for five years thereafter promulgated the law. After this deadline has expired, the number of previously approved licenses cannot be reduced.
“This point is important because the fewer actors that participate, there will be less competition., which has a direct impact on the patient ”indicated the president of the Cciap.
The business union promotes the implementation of a patient registry that is agile, friendly and confidential, both for resident and foreign patients, who can define together with the treating physician the way to use medicinal cannabis (pulmonary, creams, oils, among others).